BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25398131)

  • 1. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway.
    Cheng L; Li X; Dong W; Yang J; Li P; Qiang X; Yin J; Guo L
    J Cancer Res Clin Oncol; 2024 May; 150(5):230. PubMed ID: 38703300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4.
    Wang L; Li K; Wang C; Shi X; Yang H
    Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
    Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression.
    Lei L; Hong LL; Ling ZN; Zhong Y; Hu XY; Li P; Ling ZQ
    Clin Transl Gastroenterol; 2021 Jul; 12(7):e00377. PubMed ID: 34193800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma.
    Liu K; Wu X; Zang X; Huang Z; Lin Z; Tan W; Wu X; Hu W; Li B; Zhang L
    Oncol Res; 2017 Sep; 25(8):1329-1340. PubMed ID: 28256185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAWBP and MAWD inhibit proliferation and invasion in gastric cancer.
    Li DM; Zhang J; Li WM; Cui JT; Pan YM; Liu SQ; Xing R; Lu YY
    World J Gastroenterol; 2013 May; 19(18):2781-92. PubMed ID: 23687415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway.
    Wang C; Yang Z; Xu E; Shen X; Wang X; Li Z; Yu H; Chen K; Hu Q; Xia X; Liu S; Guan W
    Clin Transl Med; 2021 Aug; 11(8):e522. PubMed ID: 34459127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PXMP4 promotes gastric cancer cell epithelial-mesenchymal transition via the PI3K/AKT signaling pathway.
    Li W; Dong X; Wan Z; Wang W; Zhang J; Mi Y; Li R; Xu Z; Wang B; Li N; He G
    Mol Biol Rep; 2024 Feb; 51(1):350. PubMed ID: 38401002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin suppresses gastric cancer progression by reversing epithelial-mesenchymal transition via suppression of the Notch signaling pathway.
    Zang MD; Hu L; Fan ZY; Wang HX; Zhu ZL; Cao S; Wu XY; Li JF; Su LP; Li C; Zhu ZG; Yan M; Liu BY
    J Transl Med; 2017 Feb; 15(1):52. PubMed ID: 28241766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBX3 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition.
    Wang S; Li C; Wang W; Xing C
    Oncol Lett; 2016 Nov; 12(5):3485-3491. PubMed ID: 27900025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAE1 promotes gastric carcinogenesis and epithelial-mesenchymal transition.
    Dong W; Li X; Cheng L; Yang J; Zhao Z; Qiang X; Li P; Wu J; Guo L
    Arch Biochem Biophys; 2024 Apr; 754():109896. PubMed ID: 38417691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signaling.
    Lin JX; Xie XS; Weng XF; Qiu SL; Yoon C; Lian NZ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Yang YH; Huang CM; Zheng CH; Li P
    J Exp Clin Cancer Res; 2019 Sep; 38(1):410. PubMed ID: 31533855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRSF1 promotes tumorigenesis and EMT-mediated metastasis through PI3K/AKT pathway in gastric cancer.
    Wang B; Wang L; Lu Y; Liang W; Gao Y; Xi H; Chen L
    Biochem Biophys Res Commun; 2021 May; 555():61-66. PubMed ID: 33813277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging roles of CEACAM6 in human cancer (Review).
    Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
    Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 gene inhibition and TIMP-4 gene upregulation by Imperata cylindrica's root extract prevents metastasis of CaSki cells via inhibiting PI3K/Akt/snail signaling pathway and blocking EMT.
    Nayim P; Mbaveng AT; Sanjukta M; Rikesh J; Kuete V; Sudhir K
    J Ethnopharmacol; 2021 Jul; 275():114111. PubMed ID: 33848610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRIG1 inhibits hypoxia-induced vasculogenic mimicry formation via suppression of the EGFR/PI3K/AKT pathway and epithelial-to-mesenchymal transition in human glioma SHG-44 cells.
    Zhang X; Song Q; Wei C; Qu J
    Cell Stress Chaperones; 2015 Jul; 20(4):631-41. PubMed ID: 25860915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3β activation.
    Li C; Zhang J; Wu H; Li L; Yang C; Song S; Peng P; Shao M; Zhang M; Zhao J; Zhao R; Wu W; Ruan Y; Wang L; Gu J
    Sci Rep; 2017 Mar; 7():45275. PubMed ID: 28345638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer cell-derived Tie1 expression via PI3K/AKT signaling pathway promotes tumor progression.
    Wei Y; Yu P; Zhao Z; Sun C; Sun Q; Bai R; Gao W; Yang P
    Exp Cell Res; 2024 Jun; 439(1):114060. PubMed ID: 38719173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Study on the Effect and Mechanism of Xiaoaiping (XAP) Injection and S-1 Combination Therapy in Inhibiting the Invasion and Metastasis of Human GC Cells.
    Wen P; Wang H; Ni T; Dai X; Chu Z; Ma S; Xiang L; Zhou Z; Qian Y; Sunagawa M; Liu Y
    Anticancer Agents Med Chem; 2021; 21(8):1037-1046. PubMed ID: 32951585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.